Which second-generation antipsychotic does not lower blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aripiprazole and Ziprasidone Do Not Lower Blood Pressure

Among second-generation antipsychotics, aripiprazole and ziprasidone are the agents that do NOT decrease blood pressure—in fact, they may rarely cause hypertension rather than hypotension. This distinguishes them from most other atypical antipsychotics, which commonly cause orthostatic hypotension as a side effect.

Blood Pressure Effects by Agent

Agents That DO Lower Blood Pressure (Avoid if Hypotension is a Concern)

Most second-generation antipsychotics cause hypotension through various mechanisms:

  • Olanzapine: Causes hypotension and bradycardia, particularly with IM administration 1. This effect is well-documented in elderly patients 1.

  • Quetiapine: Associated with hypotension (<10% incidence) 2. Listed among agents causing orthostatic hypotension 3.

  • Risperidone: Can cause orthostatic hypotension 3, 1.

  • Clozapine: Associated with hypotension (<10% incidence) 2, though interestingly may also cause hypertension in some cases 4.

Agents That Do NOT Lower Blood Pressure

Aripiprazole and ziprasidone stand apart from other second-generation antipsychotics:

  • Aripiprazole: Tends to have fewer metabolic effects 5 and has been documented to cause asymptomatic hypertension rather than hypotension 6. This is likely related to its unique mechanism as a partial dopamine agonist rather than a pure antagonist 7.

  • Ziprasidone: Demonstrated no adverse effects on blood pressure in elderly patients 1. Studies show no significant changes in blood pressure or heart rate 1. Ziprasidone may rarely cause hypertension (<2%) 2.

Clinical Reasoning

The mechanism behind these differences relates to receptor profiles. Most atypical antipsychotics cause hypotension through:

  • Direct vasodilation
  • Alpha-adrenergic blockade
  • Histamine (H1) receptor antagonism
  • Autonomic nervous system modulation

Aripiprazole's partial dopamine agonist activity and ziprasidone's distinct receptor binding profile result in minimal effects on blood pressure regulation, making them safer choices when hypotension is a concern 1, 2.

Key Clinical Pitfall

Do not assume all second-generation antipsychotics are equivalent regarding cardiovascular effects. While orthostatic hypotension is listed as a class effect for atypical antipsychotics 3, aripiprazole and ziprasidone are notable exceptions. This distinction is critical when treating patients with:

  • Baseline hypotension
  • Cardiovascular disease
  • Elderly patients at fall risk
  • Patients on concurrent antihypertensive medications

When blood pressure stability is a priority, aripiprazole or ziprasidone should be preferentially selected over olanzapine, quetiapine, risperidone, or clozapine 1, 5.

Related Questions

How many ampoules of a 17.7% sodium solution are needed to prepare a 3% hypertonic sodium solution?
In a 1-year-old child with a migrated aortic stent, is anticoagulation indicated?
Should a postero‑anterior and lateral chest radiograph be obtained for a 10 mm nodular opacity in the left upper lung to differentiate a solitary nodule from a confluence of shadows?
Is a blood pressure of 146/84 mm Hg an indication to start antihypertensive medication?
What are the possible causes of a 28-year-old man's lower‑leg venous symptoms and poor circulation, and should he be referred to a vascular specialist for evaluation?
How should the clozapine (Clozaril) dosing schedule be clarified and simplified for a female patient with schizophrenia who is prescribed 100 mg at bedtime and 200 mg once daily?
What is the appropriate treatment for bacterial vaginosis in a 75‑year‑old woman, considering her renal function?
Which SSRI most significantly affects the Multiple Sleep Latency Test (MSLT)?
Can the clozapine dose be increased beyond the current 300 mg daily in this female patient who is tolerating it without significant side effects and has acceptable white‑blood‑cell and absolute neutrophil counts?
What are the recommended treatment options for bacterial vaginosis in adult women, including first‑line therapy, alternatives for metronidazole intolerance, and management of recurrent or refractory cases?
What ultrasound study should be performed to evaluate right upper quadrant (RUQ) pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.